•  
  •  
  •  
  •  

2026-08-12 16:39:32

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT

Keywords Selected:  INE107F01022

Stock Report

  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • No DMF deficiency letter received from the office of USFDA for multiple ANDAs
  • Wanbury Limited gets 6 observations from USFDA after cGMP inspection at Tanuku facility
  • Wanbury Ltd updates on pledged shares and interest rate reduction
  • Wanbury's Tanuku unit successfully completes Quality Inspection by TGA
  • Wanbury Ltd submits APIs for regulatory approvals
  • Wanbury's Patalganga site completes MFDS inspection successfully
  • Wanbury Strengthens Coriminic Brand with Pediatric-Focused, Regulation-Aligned Launches
  • Wanbury Ltd - Sertraline Form II approval received from ANVISA, BRAZIL
  • Wanbury Limited Q3 FY26: PAT Explodes 1,194% YoY to ₹15.8 Cr, Revenue Up 22%
  • Wanbury's Tanuku facility granted Good Manufacturing Practices Certificate by ANVISA
  • Wanbury Limited to implement the SAP S/4 HANA Private Cloud Platform
  • Wanbury Limited launching two new products, Formulation - Branded Hematinic Iron tablets, WANBURY C-RED and API- KETAMINE HYDROCHLORIDE
  • Wanbury Ltd achieves significant Interest Cost Savings through Refinancing of Outstanding Debentures
  • Wanbury Limited successfully completes ANVISA audit at its Tanuku plant
  • Wanbury's Tanuku plant at Andhra Pradesh successfully completes ANVISA inspection
  • Wanbury Ltd received CEP approval from EDQM for the launch of its new product, Dextromethorphan API
  • Wanbury receives EIR from USFDA for Patalganga facility
  • Wanbury Ltd wins two Safety Awards for its API Manufacturing Site in Patalganga
  • Wanbury Limited appoints Mr. Pradeep Patni as CEO of India Formulation Business
  • Wanbury Limited appoints Prakash Venkatraman as President of API Business
  • Wanbury Limited receives term loan facility of Rs. 60 crore from Tata Capital Ltd
  • Wanbury's Patalganga Manufacturing Facility clears US FDA Inspection with Zero Observations
  • Wanbury Ltd to raise Rs. 100 crores through NCDs

Latest Post

  • Enviro Infra Engineers Reports 49.1% Revenue Growth to ₹ 3,592 Million in Q1 FY27; PAT Rises 6.5% to ₹ 452 Million
  • Wanbury Limited Reports Q1 FY27 Revenue of ₹165.6 Crore; Refinances ₹205 Crore Debt to Cut Interest Costs
  • Popular Vehicles & Services Reports 44.6% YoY Revenue Growth to ₹1,903.1 Crore in Q1 FY27; Turns Profitable with ₹1.4 Crore PAT
  • Hirect Limited Reports 20.3% Revenue Growth in Q1 FY27; Standalone Net Profit Up 17.8% Amid Global Expansion
  • Delton Cables reports highest ever first quarterly Revenue, EBITDA & PAT


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025